Abstract
The extensive use of bisphenol A (BPA) in the manufacture of consumer products results in widespread human exposure to the chemical. In the body, BPA undergoes first-pass metabolism to form BPA glucuronide, considered to be a major BPA byproduct. Concentrations of total (free plus conjugated) urinary species of BPA are used to assess human exposure to BPA. However, because BPA can be present in numerous consumer and household products, potential contamination with parent BPA during collection and handling may pose a challenge when measuring BPA in such biological samples as blood or urine. In this study we investigated the in-vitro phase I metabolism of BPA in rat and human liver microsomes by using on-line solid-phase extraction–high-performance liquid chromatography–tandem mass spectrometry to identify phase I metabolites (e.g., BPA oxidation products) that could be used as potential alternative biomarkers of BPA exposure. We unambiguously identified 5-hydroxy BPA (BPA catechol) as an in-vitro oxidative metabolite of BPA, but human microsomes oxidized only about 10% of BPA to BPA catechol. We evaluated the usefulness of BPA catechol as a potential biomarker of human exposure to BPA by measuring total concentrations of BPA catechol and BPA in 20 urine samples. We detected BPA catechol at much lower concentrations and frequency than those of BPA. Furthermore, we found that free BPA catechol was rather unstable in urine, which highlights the importance of sampling techniques to adequate interpretation of biomonitoring data. Together, these findings suggest that BPA catechol may not be a suitable biomarker of environmental exposure to BPA, but could be used to confirm BPA exposure in special populations or in situations when urine specimens were potentially contaminated with BPA.
Similar content being viewed by others
References
Chapin RE, Adams J, Boekelheide K, Gray LE, Hayward SW, Lees PSJ, McIntyre BS, Portier KM, Schnorr TM, Selevan SG, Vandenbergh JG, Woskie SR (2008) Birth Defects Res B Dev Reprod Toxicol 83:157–395
National Toxicology Program (2008) NTP Brief on Bisphenol A (CAS no. 80-05-07)
Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ, McDonnell DP (1997) Toxicol Appl Pharmacol 143:205–212
Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D (1993) Endocrinology 132:2279–2286
Morrisey RE, George JD, Price CJ, Tyl RW, Marr MC, Kimmel CA (1987) Fundam Appl Toxicol 8:571–582
Yamasaki K, Sawaki M, Takatsuki M (2000) Environ Health Perspect 108:1147–1150
European Union (2008) Updated European Risk Assessment Report 4,4′-Isopropylidenediphenol (Bisphenol-A). Environment Addendum of February 2008 (to be read in conjunction with published EU RAR of BPA, 2003 for full details) European Union,
vom Saal FS, Hughes C (2005) Environ Health Perspect 113:926–933
Lee YJ, Ryu HY, Kim HY, Min CS, Lee JH, Kim E, Nam BH, Park JH, Jung JY, Jang DD, Park EY, Lee KH, Ma JY, Won HS, Im MW, Leem JH, Hong YC, Yoon HS (2008) Reprod Toxicol 25:413–419
Calafat AM, Ye XY, Wong LY, Reidy JA, Needham LL (2008) Environ Health Perspect 116:39–44
Kim YH, Kim CS, Park S, Han SY, Pyo MY, Yang MH (2003) Biochem Biophys Res Commun 312:441–448
Matsumoto A, Kunugita N, Kitagawa K, Isse T, Oyama T, Foureman GL, Morita M, Kawamoto T (2003) Environ Health Perspect 111:101–104
Ouchi K, Watanabe S (2002) J Chromatogr B Anal Technol Biomed Life Sci 780:365–370
Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C, Godbold J, Biro F, Kushi LH, Pfeiffer CM, Calafat AM (2007) Environ Health Perspect 115:116–121
Yang M, Kim SY, Chang SS, Lee IS, Kawamoto T (2006) Environ Mol Mutagen 47:571–578
Yang MH, Kim SY, Lee SM, Chang SS, Kawamoto T, Jang JY, Ahn YO (2003) Arch Environ Contam Toxicol 44:546–551
Ye XY, Kuklenyik Z, Needham LL, Calafat AM (2005) Anal Bioanal Chem 383:638–644
Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W (2002) Chem Res Toxicol 15:1281–1287
Moss T, Howes D, Williams FM (2000) Food Chem Toxicol 38:361–370
Hissink AM, Dunnewijk R, VanOmmen B, VanBladeren PJ (1997) Chem Biol Interact 103:17–33
Ye XY, Bishop AM, Reidy JA, Needham LL, Calafat AM (2006) Environ Health Perspect 114:1843–1846
Kadry AM, Okereke CS, Abdelrahman MS, Friedman MA, Davis RA (1995) J Appl Toxicol 15:97–102
Okereke CS, Kadry AM, Abdelrahman MS, Davis RA, Friedman MA (1993) Drug Metab Dispos 21:788–791
Kurebayashi H, Harada R, Stewart RK, Numata H, Ohno Y (2002) Toxicol Sci 68:32–42
Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM (2000) Toxicol Sci 54:3–18
Pritchett JJ, Kuester RK, Sipes IG (2002) Drug Metab Dispos 30:1180–1185
Snyder RW, Maness SC, Gaido KW, Welsch F, Sumner SCJ, Fennell TR (2000) Toxicol Appl Pharmacol 168:225–234
Knaak JB, Sullivan LJ (1966) Toxicol Appl Pharmacol 8:175–184
Yoshihara S, Makishima M, Suzuki N, Ohta S (2001) Toxicol Sci 62:221–227
Matthews JB, Twomey K, Zacharewski TR (2001) Chem Res Toxicol 14:149–157
Nakagawa Y, Suzuki T (2001) Xenobiotica 31:113–123
Atkinson A, Roy D (1995) Environ Mol Mutagen 26:60–66
Atkinson A, Roy D (1995) Biochem Biophys Res Commun 210:424–433
Edmonds JS, Nomachi M, Terasaki M, Morita M, Skelton BW, White AH (2004) Biochem Biophys Res Commun 319:556–561
Waechter J, Domoradzki J, Thornton C, Markham D (2007) Toxicol Mech Method 17:13–24
Watabe Y, Kondo T, Imai H, Morita M, Tanaka N, Hosoya K (2004) Anal Chem 76:105–109
Ye XY, Bishop AM, Reidy JA, Needham LL, Calafat AM (2007) J Expos Sci Environ Epidemiol 17:567–572
Ye X, Tao LJ, Needham LL, Calafat AM (2008) Talanta 76:865–871
Hornung RW, Reed LD (1990) Appl Occup Environ Hyg 5:46–51
Elsby R, Maggs JL, Ashby J, Park BK (2001) J Pharmacol Exp Ther 297:103–113
Calafat AM, Weuve J, Ye XY, Jia LT, Hu H, Ringer S, Huttner K, Hauser R (2009) Environ Health Perspect 117:639–644
Chin YP, Miller PL, Zeng LK, Cawley K, Weavers LK (2004) Environ Sci Technol 38:5888–5894
Suzuki T, Nakagawa Y, Takano I, Yaguchi K, Yasuda K (2004) Environ Sci Technol 38:2389–2396
Disclaimer
The use of trade names is for identification only and does not constitute endorsement by the US Department of Health and Human Services or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary materials
Below is the link to the electronic supplementary material.
ESM 1
(PDF 106 kb)
Rights and permissions
About this article
Cite this article
Ye, X., Zhou, X., Needham, L.L. et al. In-vitro oxidation of bisphenol A: Is bisphenol A catechol a suitable biomarker for human exposure to bisphenol A?. Anal Bioanal Chem 399, 1071–1079 (2011). https://doi.org/10.1007/s00216-010-4344-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-4344-x